New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery

NCT00074828 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

511

Enrollment

INDUSTRY

Sponsor class

Conditions

Total Knee Replacement
Total Hip Replacement

Interventions

DRUG: LY517717
DRUG: enoxaparin

Sponsor

Eli Lilly and Company